Overview

A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult Participants

Status:
COMPLETED
Trial end date:
2023-10-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the impact of the BMS-986419 new immediate release (IR) tablet formulation compared to the current enteric (DR) capsule formulation, and to assess the effect of food on the drug levels of the IR tablet formulation in healthy adult participants.
Phase:
PHASE1
Details
Lead Sponsor:
Bristol-Myers Squibb